94 related articles for article (PubMed ID: 20981000)
1. Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers.
Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Dijk DJ; Boyle J; Murphy MG
Clin Pharmacol Ther; 2010 Dec; 88(6):831-9. PubMed ID: 20981000
[TBL] [Abstract][Full Text] [Related]
2. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers.
James LM; Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Murphy MG; Boyle J; Dijk DJ
Psychopharmacology (Berl); 2011 Jun; 215(4):643-53. PubMed ID: 21301819
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
Dinges DF; Arora S; Darwish M; Niebler GE
Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
[TBL] [Abstract][Full Text] [Related]
5. Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients.
Sun H; MacLeod C; Mostoller K; Mahon C; Han L; Renger JJ; Ma J; Brown KR; Schulz V; Kay GG; Herring WJ; Lines C; Rosen LB; Murphy MG; Wagner JA
J Clin Pharmacol; 2013 Dec; 53(12):1294-302. PubMed ID: 24122944
[TBL] [Abstract][Full Text] [Related]
6. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
[TBL] [Abstract][Full Text] [Related]
7. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
8. Caffeine effects on recovery sleep following 27 h total sleep deprivation.
LaJambe CM; Kamimori GH; Belenky G; Balkin TJ
Aviat Space Environ Med; 2005 Feb; 76(2):108-13. PubMed ID: 15742825
[TBL] [Abstract][Full Text] [Related]
9. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
[TBL] [Abstract][Full Text] [Related]
10. Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep.
Boyle J; Stanley N; James LM; Wright N; Johnsen S; Arbon EL; Dijk DJ
J Psychopharmacol; 2012 Aug; 26(8):1047-57. PubMed ID: 21940760
[TBL] [Abstract][Full Text] [Related]
11. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness.
Inocente C; Arnulf I; Bastuji H; Thibault-Stoll A; Raoux A; Reimão R; Lin JS; Franco P
Clin Neuropharmacol; 2012; 35(2):55-60. PubMed ID: 22356925
[TBL] [Abstract][Full Text] [Related]
12. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
Wesensten NJ; Killgore WD; Balkin TJ
J Sleep Res; 2005 Sep; 14(3):255-66. PubMed ID: 16120100
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of wakefulness with lisdexamfetamine dimesylate, compared with placebo and armodafinil in healthy adult males undergoing acute sleep loss.
Gasior M; Freeman J; Zammit G; Donnelly P; Gao J; Ferreira-Cornwell MC; Roth T
J Clin Psychopharmacol; 2014 Dec; 34(6):690-6. PubMed ID: 25159886
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
15. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
16. The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans.
Wilson SJ; Bailey JE; Rich AS; Nash J; Adrover M; Tournoux A; Nutt DJ
J Psychopharmacol; 2005 Nov; 19(6):609-13. PubMed ID: 16272182
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males.
Kluge M; Schüssler P; Bleninger P; Kleyer S; Uhr M; Weikel JC; Yassouridis A; Zuber V; Steiger A
Psychoneuroendocrinology; 2008 May; 33(4):497-506. PubMed ID: 18329818
[TBL] [Abstract][Full Text] [Related]
18. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the neuroendocrine response to sleep in pediatric burn patients.
Gottschlich MM; Khoury J; Warden GD; Kagan RJ
JPEN J Parenter Enteral Nutr; 2009; 33(3):317-26. PubMed ID: 19223527
[TBL] [Abstract][Full Text] [Related]
20. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
